Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Share

RPH Pharmaceuticals AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 280,723 Less Arrow 221,246 Less Arrow 154,229
Financial expenses 19,755 More Arrow 21,546 Less Arrow 11,963
Earnings before taxes 83,050 Less Arrow 29,839 Less Arrow 24,856
EBITDA 86,542 Less Arrow 73,416 Less Arrow 49,798
Total assets 168,189 More Arrow 215,022 Less Arrow 200,924
Current assets 47,973 More Arrow 72,734 Less Arrow 63,297
Current liabilities 132,306 More Arrow 187,221 Less Arrow 170,591
Equity capital 33,985 Less Arrow 25,838 More Arrow 28,381
- share capital 65 More Arrow 67 Equal arrow 67
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 20.2% Less Arrow 12.0% More Arrow 14.1%
Turnover per employee
Profit as a percentage of turnover 29.6% Less Arrow 13.5% More Arrow 16.1%
Return on assets (ROA) 61.1% Less Arrow 23.9% Less Arrow 18.3%
Current ratio 36.3% More Arrow 38.8% Less Arrow 37.1%
Return on equity (ROE) 244.4% Less Arrow 115.5% Less Arrow 87.6%
Change turnover 66,795 Less Arrow 66,223 Less Arrow 34,076
Change turnover % 31% More Arrow 43% Less Arrow 28%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.